ApalyRx: Turn-Key Direct-to-Employer Infrastructure for Manufacturers

Manufacturers lose 40-60% of WAC to wholesaler margins, PBM spread, and rebate float held 90-180 days. No pricing control past the loading dock. No visibility into which employers actually receive their drug.

ApalyRx changes that.

We are the patent-pending, end-to-end platform that brings manufacturer direct-to-employer programs inside the employer benefit, without changing how manufacturers currently operate or ship.

Manufacturers gain pricing control to the point of dispense, real-time member-level data, locked employer formulary position, and rebates applied at dispense rather than held 90-180 days. Safety stock requirements drop dramatically against a known enrolled member census.

On the employer side, the drug lands in-benefit with full cost-share collection and claims settlement through either the employer's TPA or existing PBM. We work with the PBM. We are not a replacement.

No wholesaler. No distributor spread. No change to how manufacturers currently ship.

Every routing decision produces an independently verifiable record, proof the drug benefit operated with integrity.

apalyrx.com | jerry@apalyrx.com

Apaly Rx

Jerry Beinhauer MD

This department oversees the strategic direction and management of all marketing initiatives within the organization.

Apaly Rx

Org chart

Teams

Marketing Leadership

Offices